SINEW
欣耀生醫股份有限公司
SINEW is a Taiwan Emerging Stock Board biotechnology company, as of 2026-11-01.
Pipeline
| Asset | Target / mechanism | Stage | Indication | Region | Source date | Source |
|---|---|---|---|---|---|---|
| SNP-610 | — | — | — | — | 2025-02-27 | Company disclosure |
| SNP-630 | — | Phase 1; completed | NASH - Nonalcoholic Steatohepatitis | Taiwan | 2021-10-11 | Trial registry |
| SNP-810 | — | — | — | — | 2025-04-11 | Company disclosure |
Key events
No verified events in the past twelve months.
Related Drugnews articles
No related articles in this language.